Oak Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

Oak Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,000	Closed	-$41K	–	167
2022 Q1	$41K	Hold	10,000	–	–	0.02%	106
2021 Q4	$36K	Hold	10,000	–	–	0.01%	104
2021 Q3	$35K	Hold	10,000	–	–	0.01%	97
2021 Q2	$44K	Hold	10,000	–	–	0.02%	96
2021 Q1	$41K	Hold	10,000	–	–	0.02%	48
2020 Q4	$40K	Hold	10,000	–	–	0.02%	93
2020 Q3	$29K	Hold	10,000	–	–	0.02%	88
2020 Q2	$28K	Hold	10,000	–	–	0.02%	86
2020 Q1	$24K	Hold	10,000	–	–	0.02%	85
2019 Q4	$47K	Hold	10,000	–	–	0.03%	93
2019 Q3	$33K	Hold	10,000	–	–	0.02%	96
2019 Q2	$32K	Hold	10,000	–	–	0.02%	96
2019 Q1	$30K	Hold	10,000	–	–	0.02%	88
2018 Q4	$27K	Hold	10,000	–	–	0.02%	85
2018 Q3	$34K	Hold	10,000	–	–	0.02%	96
2018 Q2	$26K	Hold	10,000	–	–	0.02%	92
2018 Q1	$22K	Hold	10,000	–	–	0.02%	89
2017 Q4	$20K	Buy	+10,000	New	+$21.8K	0.02%	88

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Oak Asset Management's ATRS Position: Q2 2022 in Review

Oak Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 10,000 shares — an estimated $41K sold.

Oak Asset Management first reported a position in ATRS in Q4 2017 and held it in 18 quarters. The position peaked at $47K in Q4 2019. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Oak Asset Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Oak Asset Management sold 10,000 Antares Pharma, Inc. shares in Q2 2022, an estimated $41K.
Oak Asset Management first reported a position in Antares Pharma, Inc. in Q4 2017 and held it in 18 quarters.
Oak Asset Management's Antares Pharma, Inc. position peaked at $47K in Q4 2019.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Oak Asset Management's 13F filing for Q2 2022, filed 15 Jul 2022.